4.7 Editorial Material

COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Medicine, General & Internal

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Clark D. Russell et al.

LANCET (2020)

Letter Surgery

COVID-19 in kidney transplant recipients

Ilaria Gandolfini et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Letter Medicine, General & Internal

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?

Andrew I. Ritchie et al.

LANCET (2020)

Letter Medicine, General & Internal

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta et al.

LANCET (2020)

Letter Gastroenterology & Hepatology

Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic

Lorenzo D'Antiga

LIVER TRANSPLANTATION (2020)

Review Immunology

Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome

Chelsea Kotch et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)

Review Immunology

Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis

Eleni Karakike et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Biochemistry & Molecular Biology

CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade

Theodoros Giavridis et al.

NATURE MEDICINE (2018)

Review Virology

Suppression of Coronavirus Replication by Cyclophilin Inhibitors

Yoshikazu Tanaka et al.

VIRUSES-BASEL (2013)

Article Biotechnology & Applied Microbiology

Cyclosporin A inhibits the replication of diverse coronaviruses

Adriaan H. de Wilde et al.

JOURNAL OF GENERAL VIROLOGY (2011)